Monopar Therapeutics Inc. ( MNPR) - Stock Earnings
MNPR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -3.4 million USD | — USD |
| 2025Q4 | -5.2 million USD | — USD |
| 2026Q1 | -3.9 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
MNPR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -8.4 million USD | — USD |
| 2024 | -15.6 million USD | — USD |
| 2025 | -13.7 million USD | — USD |
| 2026 Est. | — | — |
MNPR
Price: $62.35
52 week price:
Earnings Per Share: -1.93 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 123422
Market Capitalization: 398.5 million